The Journal of Bone and Joint Surgery (American). 2007;89:1019-1027.
doi:10.2106/JBJS.F.00615
© 2007 The Journal of Bone and Joint Surgery, Inc.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the exam for this article:
 CME 2: April, May, June 2007 (publication date July 5, 2007; expiration dat...
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, M. V.
Right arrow Articles by Greenfield, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, M. V.
Right arrow Articles by Greenfield, E. M.
Related Collections
Right arrow Basic Science
Right arrow Oncology
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?

Inhibition of the PI3K-Akt Signaling Pathway Reduces Tumor Necrosis Factor-{alpha} Production in Response to Titanium Particles in Vitro

Matthew V. Smith, MD1, Michael J. Lee, MD1, Andrew S. Islam, MD1, Jacqueline L. Rohrer, BS2, Victor M. Goldberg, MD1, Michelle A. Beidelschies, BS3 and Edward M. Greenfield, PhD3

1 Department of Orthopaedics, Case Western Reserve University/University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106. E-mail address for M.V. Smith: mvsmith23{at}gmail.com
2 4675 Arbour Green Drive, Akron, OH 44333
3 Departments of Physiology and Biophysics (M.A.B.) and Orthopaedics (E.M.G.), Case Medical Center, Case Western Reserve University, Biomedical Research Building, Room 331, 2109 Adelbert Road, Cleveland, OH 44106. E-mail address for M.A. Beidelschies: mai6{at}case.edu. E-mail address for E.M. Greenfield: emg3{at}po.cwru.edu

Investigation performed at the Departments of Orthopaedics, Physiology and Biophysics, and Pathology, Case Western Reserve University and University Hospitals, Cleveland, Ohio

Disclosure: In support of their research for or preparation of this work, one or more of the authors received, in any one year, outside funding or grants in excess of $10,000 from the National Institutes of Health (research grant RO1 AR43769 and training grant AR07505) and three authors were supported by Allen Fellowships. Neither they nor a member of their immediate families received payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, division, center, clinical practice, or other charitable or nonprofit organization with which the authors, or a member of their immediate families, are affiliated or associated.

Background: Wear debris contributes to implant loosening after total joint arthroplasty, and few advances have been made in our ability to inhibit the biological response to wear particles. Bacterial endotoxins augment the effects of wear particles in vitro and in vivo. The cytokine, tumor necrosis factor-{alpha} (TNF-{alpha}), is produced by macrophages in response to bacterial endotoxins and wear particles, and it increases osteoclast activity resulting in bone resorption and implant loosening. The phosphoinositol-3-kinase (PI3K)-Akt intracellular signal transduction pathway contributes to cytokine production in response to soluble endotoxin. We investigated the role of the PI3K-Akt pathway in the production of TNF-{alpha} in response to wear particles with adherent endotoxin and so-called endotoxin-free wear particles.

Methods: Cultured RAW264.7 murine macrophages were incubated with titanium particles with adherent endotoxin or with endotoxin-free titanium particles in the presence and absence of specific inhibitors of PI3K (LY294002) or Akt (SH-5). Akt activation was assessed with use of Western blot. TNF-{alpha} production was measured with use of enzyme-linked immunosorbent assay. Cytotoxicity was determined by measuring lactic dehydrogenase release.

Results: Titanium particles with adherent endotoxin increased Akt activation, whereas endotoxin-free titanium particles did not. The PI3K inhibitor reduced TNF-{alpha} production by 70% in response to titanium with adherent endotoxin without increasing cytotoxicity. Similarly, the Akt inhibitor reduced TNF-{alpha} production by 83% in response to titanium particles with adherent endotoxin without increasing cytotoxicity. High concentrations of endotoxin-free titanium particles resulted in a small delayed increase in TNF-{alpha} production that was completely blocked by the PI3K inhibitor.

Conclusions: Inhibition of the PI3K-Akt pathway reduces macrophage TNF-{alpha} production in response to titanium particles with adherent endotoxin and endotoxin-free particles in vitro.

Clinical Relevance: In vivo studies are needed as these results suggest a possible pharmacological target to reduce wear particle-induced osteolysis and subsequent implant loosening.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J Am Acad Orthop SurgHome page
E. M. Greenfield and J. Bechtold
What other biologic and mechanical factors might contribute to osteolysis?
J. Am. Acad. Ortho. Surg., July 1, 2008; 16(suppl_1): S56 - S62.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. A. Babbin, A. J. Jesaitis, A. I. Ivanov, D. Kelly, M. Laukoetter, P. Nava, C. A. Parkos, and A. Nusrat
Formyl Peptide Receptor-1 Activation Enhances Intestinal Epithelial Cell Restitution through Phosphatidylinositol 3-Kinase-Dependent Activation of Rac1 and Cdc42
J. Immunol., December 15, 2007; 179(12): 8112 - 8121.
[Abstract] [Full Text] [PDF]